Elicio Therapeutics, Inc. — Director's Dealing 2021

Apr 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Angion Biomedica Corp. (ANGN)
CIK: 0001601485
Period of Report: 2021-04-15

Reporting Person: Rhodes Jennifer J (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Common Stock	S	399	$15.01	Disposed	33887	Direct

Footnotes

F1: The shares reported in this Form 4 were effected pursuant to a 10b-5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units ("RSUs") of the Issuer.